Form 4: Director Casey Tansey Receives RSU Grant at Inspire Medical
Statement of Changes in Beneficial Ownership
Director Casey M. Tansey was granted 3,562 restricted stock units as part of an equity compensation award.
Summary
- Director Casey M. Tansey acquired 3,562 restricted stock units (RSUs) on April 30, 2026.
- Each RSU represents a contingent right to receive one share of Inspire Medical Systems, Inc. common stock.
- The RSUs are subject to a vesting schedule tied to the first anniversary of service with the issuer.
- Following this transaction, the reporting person directly owns 26,286 shares of common stock.
- The reporting person maintains indirect ownership of 1,000 shares held across two family trusts.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial health.
Positives
- The equity grant aligns the director's interests with long-term shareholder value through stock-based compensation.
Negatives
- None identified.
Risks
- The value of the equity award is subject to market volatility and the future performance of Inspire Medical Systems, Inc. stock.
Future Outlook
The RSUs vest on the first anniversary of service, indicating a retention-based incentive structure for the director.
Industry Context
StockSavvy.ai notes that equity grants to board members are standard corporate governance practices designed to ensure alignment between leadership and shareholders in the medical device sector.
Comparison to Industry Standards
- The use of RSU grants for non-employee directors is consistent with compensation practices at peer medical technology companies.
- The vesting period of one year is a standard retention mechanism for board-level equity compensation.
Related Party Transactions
- The reporting person maintains indirect ownership through The Kimberly Tansey Irrevocable Trust and The Kylie Tansey Irrevocable Trust.
Stakeholder Impact
- Minimal impact on shareholders as this is a standard equity compensation event for a director.
Next Steps
- Vesting of the 3,562 RSUs upon the first anniversary of service.
Key Dates
| Date | Description |
|---|---|
| 04/30/2026 | Date of the RSU grant transaction. |
| 05/04/2026 | Date the Form 4 was filed with the SEC. |
Keywords
Inspire Medical Systems, INSP, Form 4, Insider Trading, Equity Compensation, Director Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.